ruxolitinib,parsaclisib
incyte,novartis
['ruxolitinib', 'parsaclisib']
parsaclisib plus ruxolitinib demonstrates splenic volume reduction in myelofibrosis irrespective of platelet count #eha22 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.